{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:39:59Z","timestamp":1767836399224,"version":"3.49.0"},"reference-count":47,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjph"],"accepted":{"date-parts":[[2024,4,30]]},"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>An appropriate vaccination approach is critical to control the current outbreak of mpox but there is little research providing information on its effectiveness, particularly under circumstances of limited vaccine availability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Pre-exposure vaccination campaign in the Madrid region, with the modified vaccinia Ankara-Bavarian Nordic was indicated in the risk groups from 18 July 2022.<\/jats:p>\n                  <jats:p>To evaluate the vaccine effectiveness (VE) of a dose of third-generation smallpox vaccine against mpox in the context of pre-exposure prophylaxis, a population-based indirect cohort study (Broome method) also known as test-negative design (TND) was conducted in the Madrid region (6\u2009751\u2009251 inhabitants). Logistic regression was used to obtain the adjusted VE in the TND with its time\u2013response relationship and for the sensitivity analysis the conditional logistic regression for matched case\u2013control groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>By epidemiological surveillance, 1690 suspected episodes of mpox were detected of which 799 were cases and 891 controls.<\/jats:p>\n                  <jats:p>The overall adjusted effectiveness of the pre-exposure vaccination against mpox considering an induction period of 14 days, was 86.4% (95% CI 62.2% to 95.1%). VE increases, with a statistically significant time\u2013response effect, being greater than 77.4% with a 95% confidence level from week 7. The VE at eighth week of vaccination was 99% (95% CI 81.7% to 99.9%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The effectiveness of single-dose pre-exposure vaccination against mpox seems very high. Therefore, it appears as a reliable measure to minimise the spread of mpox.<\/jats:p>\n                  <jats:p>The progressive increase in the effectiveness could justify the delay in the administration of the second dose in situations of shortage of vaccines or prioritisation in the vaccination of the maximum number of subjects at risk.<\/jats:p>\n                  <jats:p>Further studies evaluating the long-term effectiveness of the full vaccination would be appropriate.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjph-2023-000620","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:25:16Z","timestamp":1717827916000},"page":"e000620","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of pre-exposure vaccine effectiveness against mpox during the 2022\u20132023 mpox outbreak in the Madrid region (Spain): a test-negative design"],"prefix":"10.1136","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-831X","authenticated-orcid":false,"given":"Jos\u00e9 Francisco","family":"Barbas del Buey","sequence":"first","affiliation":[{"name":"Direcci\u00f3n General de Salud P\u00fablica, FIIBAP, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5375-2474","authenticated-orcid":false,"given":"Jes\u00fas","family":"\u00cd\u00f1igo Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n General de Salud P\u00fablica, Comunidad de Madrid Consejeria de Sanidad, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Alonso Garc\u00eda","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n General de Salud P\u00fablica, Comunidad de Madrid Consejeria de Sanidad, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Arag\u00f3n Pe\u00f1a","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n General de Salud P\u00fablica, Comunidad de Madrid Consejeria de Sanidad, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Montero Morales","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n General de Salud P\u00fablica, Comunidad de Madrid Consejeria de Sanidad, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4703-3024","authenticated-orcid":false,"given":"Araceli","family":"Arce Arn\u00e1ez","sequence":"additional","affiliation":[{"name":"Direcci\u00f3n General de Salud P\u00fablica, Comunidad de Madrid Consejeria de Sanidad, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,6,8]]},"reference":[{"key":"2025083109435891000_2.1.e000620.1","unstructured":"World Health Organization . Multi-country outbreak of Mpox, External situation report#14- 19 January 2023. 2023. Available: https:\/\/www.who.int\/publications\/m\/item\/multi-country-outbreak-of-mpox--external-situation-report-14--19-january-2023"},{"key":"2025083109435891000_2.1.e000620.2","unstructured":"World Health Organization . Segunda Reuni\u00f3n del Comit\u00e9 de Emergencias del Reglamento Sanitario Internacional (2005) (RSI) Sobre El Brote de Viruela S\u00edmica en Varios Pa\u00edses [Second meeting of the emergency committee of the International health regulations (2005) (IHR) on the outbreak of Monkeypox in several countries]. n.d. Available: https:\/\/bit.ly\/3P0IvMD"},{"key":"2025083109435891000_2.1.e000620.3","article-title":"A large multi-country outbreak of Monkeypox across 41 countries in the WHO European region","volume":"27","author":"Vaughan","year":"2022","journal-title":"Euro Surveill"},{"key":"2025083109435891000_2.1.e000620.4","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.27.2200471","article-title":"Monkeypox outbreak predominantly affecting men who have sex with men, Madrid, Spain, 26 April to 16 June 2022","volume":"27","author":"I\u00f1igo Mart\u00ednez","year":"2022","journal-title":"Euro Surveill"},{"key":"2025083109435891000_2.1.e000620.5","unstructured":"Ministerio de Sanidad . Alerta sobre infecci\u00f3n de viruela del mono en Espa\u00f1a y otros pa\u00edses no end\u00e9micos. Informe de situaci\u00f3n 2 de noviembre de 2022 [Alert on monkeypox infection in Spain and other non-endemic countries. 2022. Available: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/alertaMonkeypox\/docs\/Informe_de_situacion_MPX_20221102.pdf"},{"key":"2025083109435891000_2.1.e000620.6","unstructured":"Ministerio de Sanidad . Recomendaciones de vacunaci\u00f3n en el brote actual de viruela del mono. Aprobado por la Comisi\u00f3n de Salud P\u00fablica en la reuni\u00f3n mantenida el 12 de julio de 2022 [Vaccination recommendations in the current outbreak of monkeypox. Approved by the Public Health Commission at the meeting held on July 12, 2022]. 2022 Available: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/MonkeyPox\/docs\/Actualizacion_Propuesta_vacunacion_Monkeypox.pdf"},{"key":"2025083109435891000_2.1.e000620.7","unstructured":"Centres for Disease Control and Prevention . Mpox in the U.S. n.d. Available: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/smallpox-vaccine.html#anchor_1545415275064"},{"key":"2025083109435891000_2.1.e000620.8","unstructured":"UK Health Security Agency . Recommendations for the use of pre- and post-exposure vaccination during a Monkeypox incident. n.d. Available: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1100600\/recommendations-for-pre-and-post-exposure-vaccination-during-a-monkeypox-incident-26-august-2022.pdf"},{"key":"2025083109435891000_2.1.e000620.9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.14745\/ccdr.v48i78a09","article-title":"Summary of the National advisory committee on immunization (NACI) rapid response\u2014interim guidance on the use of Imvamune in the context of Monkeypox outbreaks in Canada","volume":"48","author":"Killikelly","year":"2022","journal-title":"Can Commun Dis Rep"},{"key":"2025083109435891000_2.1.e000620.10","unstructured":"European Centre for Disease Prevention and Control . Public health considerations for Mpox in EU\/EEA countries. Stockholm ECDC; 2023. Available: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/public-health-considerations-mpox-eueea-countries"},{"key":"2025083109435891000_2.1.e000620.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2006.03.012"},{"key":"2025083109435891000_2.1.e000620.12","doi-asserted-by":"crossref","first-page":"105373","DOI":"10.1016\/j.jcv.2022.105373","article-title":"Evaluation and clinical validation of Monkeypox (Mpox) virus real-time PCR assays","volume":"159","author":"Mills","year":"2023","journal-title":"J Clin Virol"},{"key":"2025083109435891000_2.1.e000620.13","unstructured":"Ministerio de Sanidad . Protocolo para la detecci\u00f3n precoz y manejo de casos ante la alerta de viruela de los monos (monkeypox) en Espa\u00f1a [Protocol for the early detection and management of cases of monkeypox alert in Spain]. Madrid Ministerio de Sanidad; 2022. Available: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/alertaMonkeypox\/docs\/ProtocoloMPX_20221102.pdf"},{"key":"2025083109435891000_2.1.e000620.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"2025083109435891000_2.1.e000620.15","unstructured":"Instituto Nacional de Estad\u00edstica . INEbase, Atlas de distribuci\u00f3n de renta de los hogares. A\u00f1o 2020: Resultados por municipios, distritos y secciones censales, Madrid. [INEbase, Atlas of household income distribution. Year 2020: Results by municipalities, districts and census sections, Madrid ]. n.d. Available: https:\/\/www.ine.es\/dyngs\/INEbase\/es\/operacion.htm?c=Estadistica_C&cid=1254736177088&menu=ultiDatos&idp=1254735976608"},{"key":"2025083109435891000_2.1.e000620.16","unstructured":"Clayton D , Hills M . Statistical Models in Epidemiology. Oxford; New York: Oxford University Press, 2013."},{"key":"2025083109435891000_2.1.e000620.17","unstructured":"Fenner F , Henderson DA , Arita I , et al . Smallpox and its eradication [World Health Organization]. 1988. Available: https:\/\/apps.who.int\/Iris\/handle\/10665\/39485"},{"key":"2025083109435891000_2.1.e000620.18","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pu.06.050185.001255"},{"key":"2025083109435891000_2.1.e000620.19","doi-asserted-by":"crossref","unstructured":"VanderWeele TJ . Confounding and effect modification: distribution and measure. Epidemiol Methods 2012;1. doi:10.1515\/2161-962X.1004","DOI":"10.1515\/2161-962X.1004"},{"key":"2025083109435891000_2.1.e000620.20","unstructured":"Instituto de Estad\u00edstica . Comunidad de Madrid. DESVAN. Banco de Datos Estructurales [Madrid\u2019s community. DESVAN. Structural data bank]. n.d. Available: https:\/\/gestiona.comunidad.madrid\/desvan\/Inicio.icm?enlace=desvan"},{"key":"2025083109435891000_2.1.e000620.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817307"},{"key":"2025083109435891000_2.1.e000620.22","unstructured":"European Medicines Agency . IMVANEX suspension for injection, summary of product characteristics. n.d. Available: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/imvanex-epar-product-information_en.pdf"},{"key":"2025083109435891000_2.1.e000620.23","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41591-023-02229-3","article-title":"Real-world effectiveness of a single dose of Mpox vaccine in males","volume":"29","author":"Wolff Sagy","year":"2023","journal-title":"Nat Med"},{"key":"2025083109435891000_2.1.e000620.24","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01612-14"},{"key":"2025083109435891000_2.1.e000620.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(08)60461-3"},{"key":"2025083109435891000_2.1.e000620.26","doi-asserted-by":"crossref","unstructured":"Joseph RE , Bozic J , Werling KL , et al . Eilat virus (EILV) causes superinfection exclusion against west NILE virus (WNV) in a strain specific manner in culex tarsalis mosquitoes . Microbiology [Preprint]. doi:10.1101\/2023.05.25.542294","DOI":"10.1101\/2023.05.25.542294"},{"key":"2025083109435891000_2.1.e000620.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001941","article-title":"Superinfection exclusion creates spatially distinct influenza virus populations","volume":"21","author":"Sims","year":"2023","journal-title":"PLoS Biol"},{"key":"2025083109435891000_2.1.e000620.28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","article-title":"Estimated effectiveness of JYNNEOS vaccine in preventing Mpox: a multijurisdictional case-control study - United States","volume":"72","author":"Dalton","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025083109435891000_2.1.e000620.29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.15585\/mmwr.mm7220a4","article-title":"Effectiveness of JYNNEOS vaccine against diagnosed Mpox infection","volume":"72","author":"Rosenberg","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025083109435891000_2.1.e000620.30","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7140e3"},{"key":"2025083109435891000_2.1.e000620.31","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7149a5"},{"key":"2025083109435891000_2.1.e000620.32","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00057-9"},{"key":"2025083109435891000_2.1.e000620.33","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine effectiveness of JYNNEOS against Mpox disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N Engl J Med"},{"key":"2025083109435891000_2.1.e000620.34","first-page":"2200883","article-title":"Post-exposure vaccine effectiveness and contact management in the Mpox outbreak","volume":"28","author":"Montero Morales","year":"2023","journal-title":"Euro Surveill"},{"key":"2025083109435891000_2.1.e000620.35","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.37.20585","article-title":"The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials","volume":"18","author":"De Serres","year":"2013","journal-title":"Euro Surveill"},{"key":"2025083109435891000_2.1.e000620.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.09.025"},{"key":"2025083109435891000_2.1.e000620.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.12.004"},{"key":"2025083109435891000_2.1.e000620.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.05.044"},{"key":"2025083109435891000_2.1.e000620.39","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-3804"},{"key":"2025083109435891000_2.1.e000620.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.04.067"},{"key":"2025083109435891000_2.1.e000620.41","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1458","article-title":"Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia","volume":"348","author":"Crowe","year":"2014","journal-title":"BMJ"},{"key":"2025083109435891000_2.1.e000620.42","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1873","article-title":"HPV vaccine protects against cervical abnormalities in young women, study finds","volume":"348","author":"Kmietowicz","year":"2014","journal-title":"BMJ"},{"key":"2025083109435891000_2.1.e000620.43","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000001116"},{"key":"2025083109435891000_2.1.e000620.44","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1662-4","article-title":"Epidemiological risk factors for adult Dengue in Singapore: an 8-year nested test negative case control study","volume":"16","author":"Yung","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2025083109435891000_2.1.e000620.45","doi-asserted-by":"publisher","DOI":"10.1097\/ede.0000000000001251"},{"key":"2025083109435891000_2.1.e000620.46","doi-asserted-by":"crossref","DOI":"10.1186\/s13317-020-00141-1","article-title":"Association between autoimmune diseases and COVID-19 as assessed in both a test-negative case-control and population case-control design","volume":"11","author":"Murtas","year":"2020","journal-title":"Auto Immun Highlights"},{"key":"2025083109435891000_2.1.e000620.47","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.15585\/mmwr.mm7135e1","article-title":"Strategies adopted by gay, Bisexual, and other men who have sex with men to prevent Monkeypox virus transmission - United States","volume":"71","author":"Delaney","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["BMJ Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjph-2023-000620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T16:44:13Z","timestamp":1756658653000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpublichealth.bmj.com\/lookup\/doi\/10.1136\/bmjph-2023-000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,6,8]]},"published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1136\/bmjph-2023-000620"],"URL":"https:\/\/doi.org\/10.1136\/bmjph-2023-000620","relation":{},"ISSN":["2753-4294"],"issn-type":[{"value":"2753-4294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}